» Articles » PMID: 14736545

Initial Steps of Insulin Signaling and Glucose Transport Are Defective in the Type 2 Diabetic Rat Heart

Overview
Journal Cardiovasc Res
Date 2004 Jan 23
PMID 14736545
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: Whole body insulin resistance and diabetes are risk factors for cardiovascular diseases, yet little is known about insulin resistance in the diabetic heart. The aim of this work was to define the insulin response in hearts of the Goto-Kakizaki (GK) rat, a polygenic model of spontaneous type 2 diabetes.

Methods: We measured D[2-3H]glucose uptake before and after insulin stimulation, plus initial steps of the insulin signaling pathway after insulin infusion via the caudal vena cava in hearts from the male Wistar and spontaneously diabetic GK rats.

Results: Despite normal basal D[2-3H]glucose uptake, insulin-stimulated glucose uptake was 50% (p<0.03) lower in GK rat hearts compared with their Wistar controls. Total GLUT4 protein was depleted by 28% (p<0.01) in GK rat hearts. We found 31% (p<0.0001) and 38% (p<0.001) decreased protein levels of insulin receptor beta (IRbeta)-subunit and insulin receptor substrate-1 (IRS-1), respectively, in GK rat hearts with 37% (p<0.02) and 45% (p<0.01) lower insulin-stimulated tyrosine phosphorylation of these proteins. Owing to the decreased IRS-1 protein levels, GK rat hearts had a 41% (p<0.0001) decrease in insulin-stimulated IRS-1 protein association with the p85 subunit of phosphatidylinositol 3-kinase, despite normal phosphatidylinositol 3-kinase protein expression. Insulin-stimulated serine phosphorylation of protein kinase B was the same in all hearts, as was protein kinase B expression.

Conclusion: We conclude that decreased insulin receptor beta, IRS-1 and GLUT4 proteins are associated with insulin resistance in type 2 diabetic rat hearts.

Citing Articles

The importance of caveolin as a target in the prevention and treatment of diabetic cardiomyopathy.

Xia W, Li X, Wu Q, Xu A, Zhang L, Xia Z Front Immunol. 2022; 13:951381.

PMID: 36405687 PMC: 9666770. DOI: 10.3389/fimmu.2022.951381.


New insights into the role of melatonin in diabetic cardiomyopathy.

Huang K, Luo X, Zhong Y, Deng L, Feng J Pharmacol Res Perspect. 2022; 10(1):e00904.

PMID: 35005848 PMC: 8929360. DOI: 10.1002/prp2.904.


Heart failure in diabetes.

Jankauskas S, Kansakar U, Varzideh F, Wilson S, Mone P, Lombardi A Metabolism. 2021; 125:154910.

PMID: 34627874 PMC: 8941799. DOI: 10.1016/j.metabol.2021.154910.


Fructose Metabolism and Cardiac Metabolic Stress.

Annandale M, Daniels L, Li X, Neale J, Chau A, Ambalawanar H Front Pharmacol. 2021; 12:695486.

PMID: 34267663 PMC: 8277231. DOI: 10.3389/fphar.2021.695486.


Insulin signaling in the heart.

Abel E Am J Physiol Endocrinol Metab. 2021; 321(1):E130-E145.

PMID: 34056923 PMC: 8321827. DOI: 10.1152/ajpendo.00158.2021.